Business Trends Defining the Future of Managed Care Pharmacy

(EDU-B6) The Path to Selection and Implementation of Value-Based Contracts

Thursday, October 13, 2022

4:30 PM – 5:45 PM ET

Location: Potomac A

ACPE UAN:0233-0000-22-050-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

Chester B. Good, MD, MPH

Senior Medical Director for Value Based Pharmacy
UPMC Health Plan
Pittsburgh, PA
Jennifer S. Graff, PharmD

Senior Director
AMCP
Alexandria, VA
Robert O'Brien, RPh

Vice President, Specialty Pharmacy
Real Endpoints
Hopewell Junction, NY

Moderator(s)

Jessica Daw, PharmD, MBA

Senior Director, Clinical Pharmacy
UPMC Health Plan
Pittsburgh, Pennsylvania

As innovative, high-cost treatment options become more available in the US health care market, there has been increasing desire among stakeholders to shift towards payment models based on treatment value and outcomes. For payers, these payment models also help share risk when therapies are approved through the expedited review pathways that offer limited evidence upon approval.

This session will review the various types of value-based arrangements with a focus on newer models and the current role of value-based arrangements among key stakeholders with examples of how best to select and utilize specific payment models.

Learning Objectives:

At the completion of this activity, participants should be able to:

Summarize the current landscape relative to the adoption of value-based arrangements among manufacturers, payers, and health systems.
Identify best practices and challenges with implementing various types of value-based arrangements.
List key considerations when determining which type of value-based arrangement to utilize in a specific situation.
Based on case studies, describe key learnings from the implementation of value-based arrangements and what payers are seeking with future value-based arrangements.